InsiderTrades

Form 4 for REGN Regeneron Pharmaceuticals

Accepted 2022-04-04 00:00:00 ET · period of report 2022-04-01 · accession 0001708138-22-000033 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2022-04-04 2022-04-01 REGN LAROSA JOSEPH J EVP GC, Secret S - Sale $690.73 -5,114 24.4K -17% -$3.53M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-04-01 S D 64 $697.35 22,153 D — —
2 Common Common Stock 2022-04-01 S D 799 $688.59 24,906 D — — (F5) Represents volume-weighted average price of sales of 799 shares of Company stock on April 1, 2022 at prices ranging from $688.05 to $688.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price.
3 Common Common Stock 2022-04-01 S D 218 $689.43 24,688 D — — (F6) Represents volume-weighted average price of sales of 218 shares of Company stock on April 1, 2022 at prices ranging from $689.07 to $689.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price.
4 Common Common Stock 2022-04-01 S D 557 $686.26 26,202 D — — (F3) Represents volume-weighted average price of sales of 557 shares of Company stock on April 1, 2022 at prices ranging from $686.15 to $686.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price.
5 Common Common Stock 2022-04-01 S D 369 $685.71 26,759 D — — (F2) Represents volume-weighted average price of sales of 369 shares of Company stock on April 1, 2022 at prices ranging from $685.49 to $685.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price.
6 Common Common Stock 2022-04-01 S D 567 $693.92 23,035 D — — (F10) Represents volume-weighted average price of sales of 567 shares of Company stock on April 1, 2022 at prices ranging from $693.62 to $693.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price.
7 Common Common Stock 2022-04-01 S D 195 $692.54 23,602 D — — (F9) Represents volume-weighted average price of sales of 195 shares of Company stock on April 1, 2022 at prices ranging from $692.10 to $692.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price.
8 Common Common Stock 2022-04-01 S D 15 $701.82 22,014 D — —
9 Common Common Stock 2022-04-01 S D 124 $698.26 22,029 D — —
10 Common Common Stock 2022-04-01 S D 497 $687.41 25,705 D — — (F4) Represents volume-weighted average price of sales of 497 shares of Company stock on April 1, 2022 at prices ranging from $687.12 to $687.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price.
11 Common Common Stock 2022-04-01 S D 254 $696.54 22,217 D — — (F13) Represents volume-weighted average price of sales of 254 shares of Company stock on April 1, 2022 at prices ranging from $696.12 to $696.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price.
12 Common Common Stock 2022-04-01 S D 305 $695.36 22,471 D — — (F12) Represents volume-weighted average price of sales of 305 shares of Company stock on April 1, 2022 at prices ranging from $695.01 to $695.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price.
13 Common Common Stock 2022-04-01 S D 259 $694.56 22,776 D — — (F11) Represents volume-weighted average price of sales of 259 shares of Company stock on April 1, 2022 at prices ranging from $694.15 to $694.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price.
14 Common Common Stock 2022-04-01 S D 641 $691.44 23,797 D — — (F8) Represents volume-weighted average price of sales of 641 shares of Company stock on April 1, 2022 at prices ranging from $691.07 to $691.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price.
15 Common Common Stock 2022-04-01 S D 250 $690.51 24,438 D — — (F7) Represents volume-weighted average price of sales of 250 shares of Company stock on April 1, 2022 at prices ranging from $690.30 to $690.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price.